Article
A myristoyl/phosphotyrosine switch regulates c-Abl.
Cell - 21 Mar 2003
Hantschel Oliver, Nagar Bhushan, Guettler Sebastian, Kretzschmar Jana, Dorey Karel, Kuriyan John, Superti-Furga Giulio
Abstract excerpt
The c-Abl tyrosine kinase is inhibited by mechanisms that are poorly understood. Disruption of these mechanisms in the Bcr-Abl oncoprotein leads to several forms of human leukemia. We found that like Src kinases, c-Abl 1b is activated by phosphotyrosine ligands. Ligand-activated c-Abl is particularly sensitive to the anti-cancer drug STI-571/Gleevec/imatinib (STI-571). The SH2 domain-phosphorylated tail...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
